Arterial stiffness is not associated with bone parameters in an elderly hyperhomocysteinemic population

S C van Dijk1, R T de Jongh2,3, A W Enneman4

  • 1Section of Geriatrics, Department of Internal Medicine, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. s.c.vandijk@erasmusmc.nl.

Insights

This study found no link between arterial stiffness and bone health in older adults with high homocysteine levels. Hyperhomocysteinemia does not appear to be a common factor connecting bone and cardiovascular diseases.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Bone Metabolism

Background:

  • Bone and cardiovascular diseases share potential links, possibly through hyperhomocysteinemia.
  • Limited data exists on this association within hyperhomocysteinemic populations.

Purpose of the Study:

  • To investigate the relationship between bone parameters and arterial stiffness in a hyperhomocysteinemic population.
  • To explore the role of homocysteine levels in these associations.

Main Methods:

  • Utilized cross-sectional and longitudinal data from the B-PROOF study (n=519).
  • Assessed bone measures (fractures, BMD, QUS) and arterial stiffness (Pwv, AI, PP) at baseline and 2-year follow-up.
  • Employed linear regression analysis and tested for homocysteine level interactions.

Main Results:

  • No significant associations were found between arterial stiffness and bone parameters (BMD, QUS) or incident fractures.
  • Homocysteine levels did not modify these associations, and adjustments for homocysteine did not alter the findings.
  • Arterial stiffness was not linked to bone health, and homocysteine did not act as a mediator or pleiotropic factor.

Conclusions:

  • Hyperhomocysteinemia is unlikely to be the driving factor behind the potential association between bone and arterial stiffness.
  • Findings suggest that the link between bone health and arterial stiffness is not explained by elevated homocysteine levels in this elderly cohort.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
704
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
641
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
340
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.7K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
802